Expression of a cloned muscarinic receptor in A9 L cells

MR Brann, NJ Buckley, SV Jones and TI Bonner

Metabolic Diseases Branch, National Institute of Diabetes, Digestive and Kidney Diseases, Bethesda, Maryland 20892.

Using an oligonucleotide based on the sequence of a porcine brain muscarinic receptor cDNA, we recently cloned four distinct muscarinic receptors from the rat and human genomes. In the present study we transfected the rat homolog of the porcine brain muscarinic receptor cDNA into A9 L cells using a mammalian expression vector and a calcium phosphate precipitation procedure. Before transfection, A9 L cells do not bind muscarinic ligands and do not express muscarinic receptor mRNA. After transfection, A9 L cells expressed muscarinic receptor mRNA and saturable, high affinity binding sites for the muscarinic antagonists 3H-quinuclidinyl benzilate and 3H-pirenzepine. The muscarinic receptor antagonists AF DX-116 and pirenzepine displaced bound 3H-quinuclidinyl benzilate with inhibition curves suggestive of a single high affinity binding site. Competition of 3H-quinuclidinyl benzilate-labeled sites with the agonists acetylcholine and carbachol yielded broad inhibition curves, consistent with a heterogeneity of binding sites. In the presence of guanine nucleotide, the agonist inhibition curves were steeper, suggesting the presence of a single low affinity site. The effects of guanine nucleotides on agonist binding are consistent with coupling of these receptors to a guanine nucleotide- binding protein (G-protein) endogenous to A9 L cells. The electrical properties of the transfected A9 L cells were examined using the whole cell patch-clamp technique. Fifty microM acetylcholine induced a conductance which reversed in polarity at -60 mV. This conductance could be reversibly blocked by atropine. These data illustrate the utility of stable transfection of A9 L cells for the characterization of individual cloned muscarinic receptors, their G-protein coupling mechanisms, and resultant physiological responses.

Volume 32, Issue 4, pp. 450-455, 10/01/1987
Copyright © 1987 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				X.-P. Huang, F. E. Williams, S. M. Peseckis, and W. S. Messer Jr. Pharmacological Characterization of Human m1 Muscarinic Acetylcholine Receptors with Double Mutations at the Junction of TM VI and the Third Extracellular Domain J. Pharmacol. Exp. Ther., September 1, 1998; 286(3): 1129 - 1139. [Abstract] [Full Text]

				S. Pepitoni and I. C.W. a. N. J. Buckley Structure of the m1 Muscarinic Acetylcholine Receptor Gene and Its Promoter J. Biol. Chem., July 4, 1997; 272(27): 17112 - 17117. [Abstract] [Full Text] [PDF]

				H. Lester Heterologous expression of excitability proteins: route to more specific drugs? Science, August 26, 1988; 241(4869): 1057 - 1063. [Abstract] [PDF]